What Arrhythmia Reviews Report on Magnesium Palpitations

Can Low Magnesium Cause Heart Palpitations?

The NHS guidance on heart palpitations states that chest pain, shortness of breath, or fainting alongside palpitations require immediate emergency medical care. The NHS says treatment depends on the cause and that an electrocardiogram (ECG) may be done.

A clinical review by Negru and colleagues (Biomedicines, 2022) associates low serum magnesium with several cardiac rhythm disturbances. The authors define hypomagnesemia as total serum magnesium below 0.65 mmol/L. However, the review emphasizes that current clinical knowledge regarding magnesium in cardiac arrhythmias remains limited and contradictory.

When Magnesium Palpitations Require Medical Care

Heart palpitations require emergency medical care if they occur alongside chest pain, breathlessness, dizziness, or fainting. The NHS explains that heart palpitations occur when a heartbeat becomes more noticeable. Common triggers include strenuous exercise, lack of sleep, stress, anxiety, alcohol, caffeine, nicotine, recreational drugs, and certain medicines.

An arrhythmia occurs when the heart beats too quickly, too slowly, or unsteadily. Arrhythmias can cause palpitations, breathlessness, dizziness, fatigue, and chest discomfort. The NHS arrhythmia guidance advises calling 999 or attending A&E for palpitations alongside chest pain, shortness of breath, lightheadedness, or feeling faint.

For palpitations that keep returning, happen more frequently, or last longer than a few minutes, the NHS advises consulting a GP. An evaluation is also indicated if an individual has an existing heart condition or a family history of heart disease. A GP may arrange an electrocardiogram and refer persistent cases to a cardiologist. The perimenopause guide covers heart palpitations during perimenopause.

What Arrhythmia Research Says About Magnesium Palpitations

Clinical reviews identify specific electrocardiogram changes and arrhythmias associated with hypomagnesemia, while noting that trial evidence remains limited. Negru and colleagues list several electrocardiogram changes observed with low magnesium levels. These findings include ST segment depression, peaked and tall or flattened T waves, and shortening of the PR interval and QTc. Arrhythmias associated with hypomagnesemia in the review include torsade de pointes, ventricular tachycardia, atrial fibrillation, premature atrial contractions, premature ventricular contractions, and supraventricular tachycardia.

The review notes that intravenous magnesium helps reverse torsade de pointes. Intravenous magnesium also reduces the ventricular response in atrial fibrillation. In symptomatic hypomagnesemia during hospital care, intravenous repletion is the preferred administration route. In outpatient care, the authors state that oral or enteral magnesium is preferred.

The review also states limits in the published evidence. The authors write that current knowledge regarding magnesium in the genesis of cardiac arrhythmias is quite limited. They point to a small number of prospective studies and much contradictory data. Large randomised trials in acute myocardial infarction failed to show any benefit of intravenous magnesium over placebo. The authors concluded that more randomised, blinded studies are necessary to evaluate clinical outcomes.

Why a Normal Blood Test Does Not Rule Out Low Magnesium

Standard serum blood tests can reflect normal magnesium concentrations even when cells experience intracellular depletion. According to Negru and colleagues, intracellular magnesium depletion can occur with normal plasma values. Serum magnesium can remain within normal physiological ranges at the cost of intracellular depletion.

Current clinical laboratory methods lack rapid assessment techniques for intracellular magnesium stores. The biomarker guide on magnesium levels explains blood testing methods, reference ranges, and test limitations. The clinical overview of magnesium deficiency symptoms details recognizable signs, high-risk populations, and why routine serum tests miss cellular depletion.

Medicines Linked to Low Magnesium

Several prescription medications are associated with renal magnesium wasting or reduced gastrointestinal absorption of magnesium. Negru and colleagues identify loop diuretics and thiazide diuretics as medications that cause renal magnesium loss. The authors also state that aminoglycoside antibiotics, amphotericin B, tacrolimus, and cyclosporine induce renal magnesium excretion. Chronic use of proton pump inhibitors reduces the gastrointestinal absorption of magnesium.

A cross-sectional observational study by Danziger and colleagues (Kidney International, 2013) evaluated 11,490 adult intensive care unit admissions. Among patients also taking diuretics, proton pump inhibitor (PPI) use was associated with 54% higher odds of hypomagnesemia. Their average serum magnesium was 0.028 mg/dl lower. The study found no association between PPI use and serum magnesium in patients who were not taking diuretics. H2 receptor antagonists showed no meaningful association with low magnesium. Danziger and colleagues concluded that clinicians should monitor serum magnesium in susceptible individuals receiving chronic proton pump inhibitor therapy alongside diuretics. Because the study evaluated critically ill hospital patients, the findings do not describe general outpatient populations.

Magnesium and HRT Evidence

Published research evaluating hormone replacement therapy and magnesium presents mixed observational data and does not report magnesium depletion. An observational study by Jurczak and colleagues (Annals of Agricultural and Environmental Medicine, 2013) evaluated 323 postmenopausal women in Poland. The researchers compared 152 women using menopausal hormone therapy against 171 women not using therapy. Higher levels of the bioelements Mg and Zn were observed in women using hormone therapy compared to controls (p<0.05).

In contrast, Orlova and colleagues (BMC Pregnancy and Childbirth, 2021) analyzed a large real-world dataset. They observed hypomagnesemia prevalence rates below 0.66 mmol/L of 21.4% in women with hormone-related conditions and 27.4% in climacteric syndrome. Using a cut-off below 0.8 mmol/L, prevalence rates were 54.8% and 58.4%. The authors write that estrogen stimulates magnesium utilization by tissues. They suggested routine screening for these groups because clinical risk factors are mostly non-specific.

These two studies point in different directions. Neither study measured heart palpitations. None of the sources on this page tested whether starting or stopping hormone therapy alters magnesium levels or heart palpitations.

What Is Not Known About Magnesium Palpitations and Supplements

None of the sources on this page tested whether magnesium supplements reduce palpitations in people with normal heart rhythm tests. No study on this page establishes magnesium deficiency as the common cause of palpitations.

The NHS advises seeing a GP when palpitations keep coming back. The sleep guide covers magnesium for sleep.